TAPS Demonstration Project

Evaluates whether oral PrEP and immediate treatment can be rolled out within a combination prevention and care approach tailored to needs of 400 HIV-negative and 300 HIV-positive female sex workers. 

*Results as of May 21 2016 presented at 2016 R4P conference in Chicago, IL: 2 arms enrolling FSW: treatment and PrEP. Enrolled 190 on PrEP. HIV prevalence of 51% in study, no seroconversions in PrEP arm. No change in reported condom use over time (high with clients, low with partners).*